<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27255" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pityriasis Rosea</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Litchman</surname>
            <given-names>Graham</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nair</surname>
            <given-names>Pragya A.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Syed</surname>
            <given-names>Hasnain A.</given-names>
          </name>
          <aff>Sheikh Zayed Hospital, Lahore</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Le</surname>
            <given-names>Jacqueline K.</given-names>
          </name>
          <aff>Desert Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Graham Litchman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pragya Nair declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hasnain Syed declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jacqueline Le declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>3</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27255.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Pityriasis rosea, also known as pityriasis circinata, roseola annulata, and herpes tonsurans maculosus, is an acute self-limiting papulosquamous disorder. The hallmark features of this condition include the development of a slightly raised, oval-shaped scaly patch called a "herald patch," followed by the emergence of multiple clusters of similar scaly oval patches within 2 weeks. These clusters&#x000a0;typically distribute in a "Christmas tree" pattern on the trunk and proximal extremities. Pityriasis rosea (PR) can sometimes be difficult to manage because of factors including variations in the clinical manifestation of the condition&#x000a0;and acknowledging instances where the typical herald patch may be absent.&#x000a0;The exact cause of&#x000a0;PR is unknown; however,&#x000a0;features like seasonal variation and community clustering suggest that it is an infectious disease. Infections like viruses, bacteria, and spirochetes,&#x000a0;as well as noninfective causes like atopy and autoimmunity, are known causes of PR. Upper respiratory tract infections that precede&#x000a0;PR suggest that streptococcus plays a role in developing this condition. Recently, reactivation of latent human herpesvirus (HHV)-6 and HHV-7 infections have been&#x000a0;identified as possible etiologic agents. This activity aims to empower healthcare professionals with the necessary tools to recognize, evaluate, and manage pityriasis rosea, highlighting the significance of an interprofessional approach in optimizing patient outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the characteristic skin presentations of pityriasis rosea (PR).</p></list-item><list-item><p>Compare all the investigation options available for PR.</p></list-item><list-item><p>Apply current evidence-based treatment options for PR.</p></list-item><list-item><p>Implement interprofessional team strategies for improving care, coordination, and communication for patients with PR.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27255&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27255">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27255.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Pityriasis rosea (PR), meaning&#x000a0;rose-colored scale, is an acute self-limiting papulosquamous disorder. <xref ref-type="bibr" rid="article-27255.r1">[1]</xref>&#x000a0;Also known as pityriasis circinata, roseola annulata, and herpes tonsurans maculosus, PR is often distinguished by&#x000a0;the development of a slightly raised, oval, scaly patch called the "herald patch." It is later followed by multiple clusters of scaly oval patches on the trunk and proximal extremities in a "Christmas tree" appearance.&#x000a0;The skin eruption usually lasts 6 to 8 weeks and although it usually begins with a pathognomic herald&#x000a0;patch, some cases are reported that may not exhibit this characteristic finding.&#x000a0;<xref ref-type="bibr" rid="article-27255.r2">[2]</xref><xref ref-type="bibr" rid="article-27255.r3">[3]</xref><xref ref-type="bibr" rid="article-27255.r4">[4]</xref></p>
      </sec>
      <sec id="article-27255.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The exact cause of&#x000a0;PR is unknown; however,&#x000a0;features like seasonal variation and community clustering suggest that it has an infection-based origin. Infections from viruses, bacteria, and spirochetes,&#x000a0;as well as noninfective causes like atopy and autoimmunity, are known causes of PR.&#x000a0;<xref ref-type="bibr" rid="article-27255.r5">[5]</xref><xref ref-type="bibr" rid="article-27255.r6">[6]</xref> Upper respiratory tract infections that precede&#x000a0;PR suggest that streptococcus plays a role in developing this condition. Recently, reactivation of latent human herpesvirus (HHV)-6 and HHV-7 infections have been&#x000a0;identified as possible etiologic agents.&#x000a0;<xref ref-type="bibr" rid="article-27255.r7">[7]</xref></p>
        <p>PR-like eruptions have been reported after vaccinations, such as bacillus Calmette-Gu&#x000e9;rin (BCG), influenza, influenza A (H1N1), diphtheria, smallpox, hepatitis B, pneumococcus, and COVID-19. <xref ref-type="bibr" rid="article-27255.r8">[8]</xref>&#x000a0;Eruptions have also been seen after administration of drugs like gold compounds, captopril, barbiturates, D-penicillamine, clonidine, angiotensin-converting&#x000a0;enzyme&#x000a0;inhibitors, nonsteroidal anti-inflammatory&#x000a0;drugs, hydrochlorothiazide, atypical&#x000a0;antipsychotics, imatinib, metronidazole, isotretinoin, and clozapine. <xref ref-type="bibr" rid="article-27255.r9">[9]</xref>&#x000a0;In temperate regions, PR is more common in the winter,&#x000a0;whereas in tropical areas, some seasonal variation is noted.&#x000a0;<xref ref-type="bibr" rid="article-27255.r10">[10]</xref><xref ref-type="bibr" rid="article-27255.r11">[11]</xref><xref ref-type="bibr" rid="article-27255.r12">[12]</xref></p>
      </sec>
      <sec id="article-27255.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The approximate incidence of&#x000a0;PR is 0.5% to 2%.&#x000a0;The condition affects&#x000a0;men and women, but studies reveal it is more commonly seen in women.&#x000a0;<xref ref-type="bibr" rid="article-27255.r13">[13]</xref>&#x000a0;Adolescents and adults&#x000a0;between 15 and 30 are most frequently affected, but&#x000a0;PR also affects older adults and children.&#x000a0;<xref ref-type="bibr" rid="article-27255.r14">[14]</xref><xref ref-type="bibr" rid="article-27255.r15">[15]</xref>&#x000a0;More cases of PR&#x000a0;are seen&#x000a0;in the monsoon and fall seasons.&#x000a0;<xref ref-type="bibr" rid="article-27255.r16">[16]</xref></p>
      </sec>
      <sec id="article-27255.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of&#x000a0;PR is not entirely understood. However, a lack of natural killer (NK) cell and B-cell activity in PR lesions has been noted, suggesting a predominantly T-cell&#x02013;mediated immunity. Increased CD4 T-cells and Langerhans cells are present in the dermis, possibly reflecting viral antigen processing and presentation.&#x000a0;<xref ref-type="bibr" rid="article-27255.r17">[17]</xref> Anti-immunoglobulin M (IgM) keratinocytes have&#x000a0;been found in patients with PR. This&#x000a0;may be associated with the exanthem phase of viral infection.&#x000a0;<xref ref-type="bibr" rid="article-27255.r18">[18]</xref></p>
      </sec>
      <sec id="article-27255.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Although skin biopsy is not necessary to diagnose pityriasis, when performed, it usually reveals many nonspecific&#x000a0;features similar to those seen in chronic dermatitis. Characteristic features include the absence or regression of the granular cell layer and extravasation of red blood cells in the papillary dermis and partly into the epidermis. Dyskeratosis, liquefaction of basal cells, papillary collagen homogenization, and intraepidermal vesicles are also evident. Notably,&#x000a0;biopsies from herald patches show minor differences from the secondary lesions.&#x000a0;<xref ref-type="bibr" rid="article-27255.r19">[19]</xref></p>
      </sec>
      <sec id="article-27255.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>PR&#x000a0;is characterized clinically by a herald patch, or mother patch, followed by scaly oval plaques on the trunk and proximal extremities along the Langer lines of cleavage, giving a characteristic "Christmas tree" appearance. Collarette scaling is common.&#x000a0;Pruritus is severe in 25% of cases. The herald patch is seen in 50% to 90% of patients and is located on the trunk, followed by the neck or proximal extremity. Over&#x000a0;1 to&#x000a0;2 weeks after the onset of the herald patch, a generalized skin eruption occurs, in which numerous lesions develop in crops. The eruption&#x000a0;is usually preceded by a prodrome of a sore throat, gastrointestinal disturbance, fever, and arthralgia.&#x000a0;<xref ref-type="bibr" rid="article-27255.r20">[20]</xref>&#x000a0;The&#x000a0;resulting lesions are symmetric and most commonly involve the thorax, back, abdomen, and adjoining areas of the neck and extremities.</p>
        <p>These secondary lesions occur as macules and papules that are elliptical or ovular in shape. Fine scaling and central wrinkling with a cigarette-paper aspect are seen. A characteristic feature of PR is the collarette appearance of the scale, with edges peripherally attached and lifted near the center of the lesion. The distribution of the lesions is usually bilateral and diffuse, with the long axis running parallel to skin tension lines.</p>
        <p>The incidence of atypical&#x000a0;PR is 20%, which may be due to the morphology, size, and distribution of lesions, as well as the symptoms or course of the condition. The various <bold>atypical</bold> morphologies include:&#x000a0;<xref ref-type="bibr" rid="article-27255.r21">[21]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Vesicular PR:</bold>&#x000a0;This condition presents as a generalized eruption of 2- to 6-mm vesicles or as a rosette of vesicles, mainly over the head, palms, and soles; it&#x000a0;is commonly seen in children and needs to be differentiated from varicella and dyshidrosis.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Purpuric (hemorrhagic) PR:</bold> This condition presents as macular purpura on the skin or oral mucosa.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>
<bold>Urticarial&#x000a0;PR</bold>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Generalized papular&#x000a0;PR:</bold> This condition presents as multiple papules that occur along with classic patches and plaques; it is seen&#x000a0;in young children, pregnant women, and African Caribbeans.&#x000a0;&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Lichenoid&#x000a0;PR:</bold> This condition is observed in the course of&#x000a0;atypical PR,&#x000a0;but it is more commonly caused by drugs such as gold compounds, captopril, barbiturates, D-penicillamine, and clonidine.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Erythema multiforme&#x02013;like&#x000a0;PR:</bold> This condition presents with targetoid lesions along with the classical lesions of PR. Histopathologically, erythema multiform&#x000a0;and&#x000a0;PR may show similar features except for satellite cell necrosis, a distinguishing feature seen only in&#x000a0;erythema multiform&#x000a0;where lymphocytes are attached to scattered necrotic keratinocytes.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Follicular PR:</bold> The secondary lesions of&#x000a0;this condition are typically follicular and present discretely or in groups associated with classical lesions. Differential diagnoses include follicular lichen planus, keratosis pilaris, and atopic dermatitis with a follicular element.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Giant&#x000a0;PR:</bold> This condition consists of plaques and circles of very large sizes ranging from 5 to 7 cm, with individual lesions reaching the size of the patient's palm; it was&#x000a0;named after Darierand and is rarely reported.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>
<bold>PR presenting as exfoliative dermatitis</bold>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>PR with atypical herald patch:</bold>&#x000a0;The herald patch may be absent in 20% of patients; alternately, this condition&#x000a0;may present with secondary eruptions or occur at unusual sites such as the face, scalp, genitalia, or other sites.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Inverse PR:</bold>&#x000a0;In this condition, lesions are predominantly present in acral and flexural areas involving the axilla, groin, and face.&#x000a0;<xref ref-type="bibr" rid="article-27255.r22">[22]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Acral PR:</bold> In this condition, lesions are more concentrated over acral parts of the body (ie, palms and soles), where erythema multiforme, syphilis, necrolytic acral erythema, and drug eruptions should be kept as differentials.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Unilateral&#x000a0;PR:</bold>&#x000a0;This rare variant of PR can be seen in both children and adults;&#x000a0; lesions are located on one side of the body, and patients&#x000a0;exhibit a herald patch with classical secondary lesions.&#x000a0;<xref ref-type="bibr" rid="article-27255.r23">[23]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Blaschkoid PR:</bold>&#x000a0;In this condition, the PR lesions follow the lines of Blaschko.&#x000a0;<xref ref-type="bibr" rid="article-27255.r24">[24]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Limb-girdle PR:</bold> Also known as&#x000a0;PR of Vidal, eruptions in this condition are limited to the shoulders or pelvic girdle, thus involving the axilla and groin; lesions are usually larger and more annular.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Mucosal involvement in PR:</bold>&#x000a0;This variant is seen in 16% of patients with PR; it affects the oral mucosa,&#x000a0;with punctuate, erosive, bullous, hemorrhages, ulcers (with or without raised borders), petechiae, papulovesicular, bullae, and erythematous plaques.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Localized PR:</bold> In this condition, eruptions are localized to one part of the body.</p>
          </list-item>
        </list>
        <p>The rashes of&#x000a0;PR usually last for 5 weeks and resolve by 8 weeks in more than 80% of patients. PR needs to be differentiated from secondary syphilis, dermatophytosis, guttate psoriasis, nummular eczema, pityriasis lichenoid chronic, cutaneous T-cell lymphoma, and erythema annular centrifugal and erythema chronic migrans.</p>
      </sec>
      <sec id="article-27255.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Dermatoscopy helps differentiate&#x000a0;PR from other conditions.&#x000a0;This technique shows a yellowish background color, a peripheral arrangement of the scales, and a patchy distribution of loosely arranged dotted vessels.&#x000a0;<xref ref-type="bibr" rid="article-27255.r25">[25]</xref></p>
        <p>Histopathology shows superficial perivascular dermatitis. Focal parakeratosis in mounds, hyperplasia, and focal spongiosis are observed in the epidermis. The epidermis may also show exocytosis of lymphocytes, variable spongiosis, mild acanthosis, and a thinned granular layer. Extravasated red blood cells and a perivascular infiltrate of lymphocytes, histiocytes, and eosinophils are seen in the dermis.&#x000a0;<xref ref-type="bibr" rid="article-27255.r3">[3]</xref><xref ref-type="bibr" rid="article-27255.r26">[26]</xref><xref ref-type="bibr" rid="article-27255.r27">[27]</xref></p>
      </sec>
      <sec id="article-27255.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>PR&#x000a0;is a self-limiting, exanthematous disease. Other than general measures like using moisturizers, bathing with soap alternatives, and cautiously exposing skin to sunlight without burning, some specific treatments may also be used. Most patients respond to emollients, antihistamines, and topical steroids. Macrolides and acyclovir&#x000a0;lead to faster resolution of lesions and help to relieve pruritus. <xref ref-type="bibr" rid="article-27255.r4">[4]</xref>&#x000a0;Narrowband ultraviolet B therapy is also used; it alters the immune response in the skin and has shown favorable results in patients.&#x000a0;<xref ref-type="bibr" rid="article-27255.r28">[28]</xref></p>
      </sec>
      <sec id="article-27255.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Lesions of PR resemble and must be differentiated from:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Erythema multiforme&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Guttate psoriasis</p>
          </list-item>
          <list-item>
            <p>Kaposi sarcoma</p>
          </list-item>
          <list-item>
            <p>Lichen planus</p>
          </list-item>
          <list-item>
            <p>Parapsoriasis</p>
          </list-item>
          <list-item>
            <p>Pediatric syphilis</p>
          </list-item>
          <list-item>
            <p>Pityriasis alba</p>
          </list-item>
          <list-item>
            <p>Seborrheic dermatitis</p>
          </list-item>
          <list-item>
            <p>Tinea corporis</p>
          </list-item>
          <list-item>
            <p>Tinea versicolor</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27255.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Pityriasis rosea typically follows a self-limiting and benign clinical course. The condition commonly resolves spontaneously within weeks to a few months. Symptomatically, mild-to-moderate itching might accompany the rash, but the overall impact on health is minimal for most individuals. Recurrence is rare (&#x0003c; 5%), with most cases presenting as a singular occurrence in a person's lifetime. Complications such as secondary bacterial infections due to scratching are infrequent. While certain systemic associations have been proposed, they remain less common. Timely diagnosis by a healthcare professional ensures appropriate guidance and reassurance, considering the generally favorable prognosis of pityriasis rosea.&#x000a0;<xref ref-type="bibr" rid="article-27255.r29">[29]</xref></p>
      </sec>
      <sec id="article-27255.s12" sec-type="Complications">
        <title>Complications</title>
        <p>PR usually resolves on its own within a few weeks or months without serious complications; however, in rare cases, some people may experience complications, including:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Superimposed bacterial infection:&#x000a0;</bold>Scratching the involved skin area can lead to a secondary bacterial infection, which can cause additional symptoms such as pain, redness, and pus.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Itching, discomfort, and impaired quality of life:</bold>&#x000a0;PR can cause intense pruritus, especially during the early stages of the condition, which can cause sleep disturbances and affect quality of life.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Hyperpigmentation:</bold> In some cases, the rash may leave behind darkened patches of skin that can take several months to fade.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Recurrence:</bold>&#x000a0;Although&#x000a0;uncommon, some people may experience a recurrence of the rash, usually within the first few months after the initial episode.</p>
          </list-item>
        </list>
        <p>Other rare complications seen in a few reported cases include premature delivery and fetal demise during pregnancy&#x000a0;(within the first trimester up to 15 weeks of gestation)&#x000a0;and drug hypersensitivity reaction due to reactivation of&#x000a0;HHV-6&#x000a0;and HHV-7.</p>
      </sec>
      <sec id="article-27255.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Deterrence measures for&#x000a0;PR include avoiding close contact with infected individuals and maintaining good hygiene practices, which can help reduce the spread of the condition and prevent new cases.</p>
        <p>Patient education is also an essential aspect of managing PR. Patients should be educated about the nature of the condition, its expected course, and the need for symptomatic relief. Patients should be informed that the condition is usually self-limiting and that the rash will resolve without specific treatment. However, symptomatic relief can be achieved through topical corticosteroids, antihistamines, and moisturizers.</p>
        <p>Patients should be advised to avoid harsh soaps, hot water, and excessive sun exposure, as these can exacerbate the rash and delay healing.&#x000a0;It is also advisable that patients&#x000a0;wear loose-fitting clothing and avoid activities that may cause excessive sweating, as this can also worsen the rash.</p>
        <p>Lastly, patients should be&#x000a0;urged&#x000a0;to seek medical attention&#x000a0;if they experience severe symptoms, such as severe itching, pain, or fever. In such cases, further investigation may be necessary to rule out other underlying conditions that may mimic the physical presentation of PR.</p>
      </sec>
      <sec id="article-27255.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>In the majority of patients,&#x000a0;PR is a self-limited condition with an excellent prognosis; however, about 2%-3% of patients will experience a recurrence. The skin disorder is benign, noncontagious, and does not require any special precautions. Since most patients first present to their primary care provider when the skin lesions appear, nurses, pharmacists, and primary care providers&#x000a0;should inform&#x000a0;patients that the condition is benign and&#x000a0;does not last for more than 2 months.</p>
        <p>For severe cases, a dermatology referral should be made. The&#x000a0;main morbidity is due to pigmentation changes, especially in dark-skinned individuals; however, scarring does not occur. There are reports that&#x000a0;PR&#x000a0;during pregnancy may be associated with premature birth, but it is not known if this is just a coincidental observation. Patients should be advised to&#x000a0;avoid applying irritants to the skin and avoid tanning. The itching that accompanies&#x000a0;PR is mild and usually resolves with a moisturizer. Exposure to the sun may induce pigmentary changes and should be avoided.&#x000a0;<xref ref-type="bibr" rid="article-27255.r30">[30]</xref><xref ref-type="bibr" rid="article-27255.r31">[31]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-27255.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27255&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27255">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/pityriasis-rosea/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=27255">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27255/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27255">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-27255.s16">
        <fig id="article-27255.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Pityriasis Rosea <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pityriasis__rosea" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-27255.s17">
        <fig id="article-27255.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Collarette sign seen in pityriasis rosea Contributed by Dr. Hasnain Ali Syed</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pityriasis__rosea1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-27255.s18">
        <title>References</title>
        <ref id="article-27255.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leung</surname>
                <given-names>AKC</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Leong</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Hon</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis Rosea: An Updated Review.</article-title>
            <source>Curr Pediatr Rev</source>
            <year>2021</year>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>201</fpage>
            <page-range>201-211</page-range>
            <pub-id pub-id-type="pmid">32964824</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drago</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ciccarese</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Parodi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them?</article-title>
            <source>JAAD Case Rep</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>4</volume>
            <issue>8</issue>
            <fpage>800</fpage>
            <page-range>800-801</page-range>
            <pub-id pub-id-type="pmid">30246131</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trayes</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Savage</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Studdiford</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Annular Lesions: Diagnosis and Treatment.</article-title>
            <source>Am Fam Physician</source>
            <year>2018</year>
            <month>Sep</month>
            <day>01</day>
            <volume>98</volume>
            <issue>5</issue>
            <fpage>283</fpage>
            <page-range>283-291</page-range>
            <pub-id pub-id-type="pmid">30216021</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chang</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Sung</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>The efficacy of oral acyclovir during early course of pityriasis rosea: a systematic review and meta-analysis.</article-title>
            <source>J Dermatolog Treat</source>
            <year>2019</year>
            <month>May</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>288</fpage>
            <page-range>288-293</page-range>
            <pub-id pub-id-type="pmid">30109959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LENNHOFF</surname>
                <given-names>VC</given-names>
              </name>
            </person-group>
            <article-title>Demonstration of spirochaetes in puncture fluid from axillary lymph glands of two cases of pityriasis rosea (mercuric-sulfide stain).</article-title>
            <source>Acta Derm Venereol</source>
            <year>1949</year>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>524</fpage>
            <page-range>524-8</page-range>
            <pub-id pub-id-type="pmid">18153199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahajan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Relhan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Relhan</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>VK</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects.</article-title>
            <source>Indian J Dermatol</source>
            <year>2016</year>
            <season>Jul-Aug</season>
            <volume>61</volume>
            <issue>4</issue>
            <fpage>375</fpage>
            <page-range>375-84</page-range>
            <pub-id pub-id-type="pmid">27512182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahroum</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shoenfeld</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Classic Pityriasis Rosea.</article-title>
            <source>Isr Med Assoc J</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>24</volume>
            <issue>8</issue>
            <fpage>549</fpage>
            <pub-id pub-id-type="pmid">35972001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khattab</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Christaki</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pitsios</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis Rosea Induced by COVID-19 Vaccination.</article-title>
            <source>Eur J Case Rep Intern Med</source>
            <year>2022</year>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>003164</fpage>
            <pub-id pub-id-type="pmid">35265550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gammoudi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Abdessayed</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Denguezli</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Domperidone-induced pityriasis rosea-like drug eruption.</article-title>
            <source>Clin Case Rep</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>e05674</fpage>
            <pub-id pub-id-type="pmid">35414911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r10">
          <label>10</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gay</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Huq</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Saleh</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>GP</given-names>
              </name>
            </person-group>
            <chapter-title>Herald Patch</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>2</month>
            <day>15</day>
            <pub-id pub-id-type="pmid">30020673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Engelmann</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ogiez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ogiez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Alidjinou</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Lazrek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dewilde</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hober</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Relapsing Pityriasis Rosea With HHV-7 Reactivation in an 11-Year-Old Girl.</article-title>
            <source>Pediatrics</source>
            <year>2018</year>
            <month>May</month>
            <volume>141</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">29674359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alame</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Chamsy</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Zaraket</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis rosea-like eruption associated with ondansetron use in pregnancy.</article-title>
            <source>Br J Clin Pharmacol</source>
            <year>2018</year>
            <month>May</month>
            <volume>84</volume>
            <issue>5</issue>
            <fpage>1077</fpage>
            <page-range>1077-1080</page-range>
            <pub-id pub-id-type="pmid">29520857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aytekin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Akdeniz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Inal&#x000f6;z</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>An epidemiological study of pityriasis rosea in the Eastern Anatolia.</article-title>
            <source>Eur J Epidemiol</source>
            <year>1998</year>
            <month>Jul</month>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>495</fpage>
            <page-range>495-7</page-range>
            <pub-id pub-id-type="pmid">9744683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>VanRavenstein</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Edlund</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of pityriasis rosea.</article-title>
            <source>Nurse Pract</source>
            <year>2017</year>
            <month>Jan</month>
            <day>20</day>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-11</page-range>
            <pub-id pub-id-type="pmid">28002142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gandhi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Agrawal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Verma</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mohite</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pattern of Papulosquamous Disorders in Children: A Clinico-Epidemiological Study.</article-title>
            <source>Cureus</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>e21194</fpage>
            <pub-id pub-id-type="pmid">35186517</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ayanlowo</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Akinkugbe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Olumide</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>The pityriasis rosea calendar: a 7 year review of seasonal variation, age and sex distribution.</article-title>
            <source>Nig Q J Hosp Med</source>
            <year>2010</year>
            <season>Jan-Mar</season>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-31</page-range>
            <pub-id pub-id-type="pmid">20450028</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Veraldi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Spigariolo</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis rosea and COVID-19.</article-title>
            <source>J Med Virol</source>
            <year>2021</year>
            <month>Jul</month>
            <volume>93</volume>
            <issue>7</issue>
            <fpage>4068</fpage>
            <pub-id pub-id-type="pmid">33205836</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drago</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ciccarese</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis rosea during COVID-19 and its pathogenesis.</article-title>
            <source>JAAD Int</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>9</volume>
            <fpage>159</fpage>
            <page-range>159-160</page-range>
            <pub-id pub-id-type="pmid">36213728</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prasad</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mittal</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Walia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Popli</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis rosea: A histopathologic study.</article-title>
            <source>Indian J Dermatol Venereol Leprol</source>
            <year>2000</year>
            <season>Sep-Oct</season>
            <volume>66</volume>
            <issue>5</issue>
            <fpage>244</fpage>
            <page-range>244-6</page-range>
            <pub-id pub-id-type="pmid">20877089</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drago</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ciccarese</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Broccolo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cozzani</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Parodi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis Rosea in Children: Clinical Features and Laboratory Investigations.</article-title>
            <source>Dermatology</source>
            <year>2015</year>
            <volume>231</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-14</page-range>
            <pub-id pub-id-type="pmid">25997658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ciccarese</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Drago</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Atypical presentations of pityriasis rosea: a reply.</article-title>
            <source>Dermatol Online J</source>
            <year>2017</year>
            <month>Aug</month>
            <day>15</day>
            <volume>23</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">29469755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fetoui</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Boussofara</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Inverse Pityriasis Rosea.</article-title>
            <source>Indian Pediatr</source>
            <year>2019</year>
            <month>Nov</month>
            <day>15</day>
            <volume>56</volume>
            <issue>11</issue>
            <fpage>981</fpage>
            <pub-id pub-id-type="pmid">31729335</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghariani Fetoui</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Boussofara</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gammoudi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Belajouza</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ghariani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Denguezli</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Unilateral pityriasis rosea.</article-title>
            <source>Int J Dermatol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>e27</fpage>
            <page-range>e27-e28</page-range>
            <pub-id pub-id-type="pmid">31646609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhanja</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Sil</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chakraborty</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Panigrahi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Punithakumar</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Symmetric blaschkoid pityriasis rosea in a child.</article-title>
            <source>Pediatr Dermatol</source>
            <year>2021</year>
            <month>May</month>
            <volume>38</volume>
            <issue>3</issue>
            <fpage>701</fpage>
            <page-range>701-703</page-range>
            <pub-id pub-id-type="pmid">33742484</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vasisht</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kansal</surname>
                <given-names>NK</given-names>
              </name>
            </person-group>
            <article-title>Dermoscopic features of pityriasis rosea.</article-title>
            <source>BMJ Case Rep</source>
            <year>2023</year>
            <month>Oct</month>
            <day>10</day>
            <volume>16</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">37816577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodriguez-Zuniga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Garcia-Perdomo</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of acyclovir in the treatment of pityriasis rosea. A systematic review and meta-analysis.</article-title>
            <source>An Bras Dermatol</source>
            <year>2018</year>
            <season>Sep-Oct</season>
            <volume>93</volume>
            <issue>5</issue>
            <fpage>686</fpage>
            <page-range>686-695</page-range>
            <pub-id pub-id-type="pmid">30156618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sonthalia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zawar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Priya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Srivastava</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low-dose oral prednisolone in pityriasis rosea.</article-title>
            <source>J Dermatolog Treat</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>29</volume>
            <issue>6</issue>
            <fpage>617</fpage>
            <page-range>617-622</page-range>
            <pub-id pub-id-type="pmid">29363373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krishnamurthy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gropper</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>To treat or not to treat? Management of guttate psoriasis and pityriasis rosea in patients with evidence of group A Streptococcal infection.</article-title>
            <source>J Drugs Dermatol</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>241</fpage>
            <page-range>241-50</page-range>
            <pub-id pub-id-type="pmid">20232586</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>F&#x000f6;lster-Holst</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zawar</surname>
                <given-names>VP</given-names>
              </name>
              <name>
                <surname>Chuh</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Paraviral exanthems.</article-title>
            <source>Expert Rev Anti Infect Ther</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>601</fpage>
            <page-range>601-11</page-range>
            <pub-id pub-id-type="pmid">27144956</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cook</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Crutchfield</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis rosea.</article-title>
            <source>Dermatol Nurs</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>370</fpage>
            <pub-id pub-id-type="pmid">16948385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27255.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Black</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Pellett</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Human herpesvirus 7.</article-title>
            <source>Rev Med Virol</source>
            <year>1999</year>
            <season>Oct-Dec</season>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>245</fpage>
            <page-range>245-62</page-range>
            <pub-id pub-id-type="pmid">10578120</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
